GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xenon Pharmaceuticals Inc (FRA:XP0) » Definitions » Other Long Term Assets

Xenon Pharmaceuticals (FRA:XP0) Other Long Term Assets : €17.51 Mil (As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Xenon Pharmaceuticals Other Long Term Assets?

Xenon Pharmaceuticals's other long-term assets for the quarter that ended in Mar. 2025 was €17.51 Mil.

Xenon Pharmaceuticals's quarterly other long-term assets increased from Sep. 2024 (€7.68 Mil) to Dec. 2024 (€16.39 Mil) and increased from Dec. 2024 (€16.39 Mil) to Mar. 2025 (€17.51 Mil).

Xenon Pharmaceuticals's annual other long-term assets declined from Dec. 2022 (€7.80 Mil) to Dec. 2023 (€7.52 Mil) but then increased from Dec. 2023 (€7.52 Mil) to Dec. 2024 (€16.39 Mil).

Xenon Pharmaceuticals Other Long Term Assets Historical Data

The historical data trend for Xenon Pharmaceuticals's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xenon Pharmaceuticals Other Long Term Assets Chart

Xenon Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.43 0.41 7.80 7.52 16.39

Xenon Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.09 7.57 7.68 16.39 17.51

Xenon Pharmaceuticals Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Xenon Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xenon Pharmaceuticals Inc (FRA:XP0) » Definitions » Other Long Term Assets
Comparable Companies
CPRX VKTX MRUS PTGX CRNX SRRK MLTX IMVT AKRO ACAD VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
XENE:USA
Address
200-3650 Gilmore Way, Burnaby, BC, CAN, V5G 4W8
Website
https://www.xenon-pharma.com
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Xenon Pharmaceuticals Headlines

No Headlines